Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCash Due from BankCommon EquityConstruction in ProgressFed Funds SoldGoodwillGoodwill & IntangiblesIntangiblesInterest DepositsLiabilities and Shareholders EquityLoansLoans - GrossLoans - Loss AllowanceLoans - NetLong-Term Deferred TaxMinority InterestNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)Receivables - AccuredRetained EarningsSecurities - Held-to-maturitySecurities - TradableShareholder's EquityShort-term InvestmentsTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

RBB Bancorp (RBB) Cash & Equivalents (2017 - 2025)

RBB Bancorp's Cash & Equivalents history spans 9 years, with the latest figure at $36.1 million for Q4 2025.

  • For Q4 2025, Cash & Equivalents fell 86.0% year-over-year to $36.1 million; the TTM value through Dec 2025 reached $36.1 million, down 86.0%, while the annual FY2025 figure was $36.1 million, 86.0% down from the prior year.
  • Cash & Equivalents reached $36.1 million in Q4 2025 per RBB's latest filing, roughly flat from $36.0 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $694.4 million in Q4 2021 to a low of $7.9 million in Q3 2023.
  • Average Cash & Equivalents over 5 years is $296.4 million, with a median of $293.4 million recorded in 2023.
  • Peak YoY movement for Cash & Equivalents: plummeted 95.47% in 2023, then soared 4326.02% in 2024.
  • A 5-year view of Cash & Equivalents shows it stood at $694.4 million in 2021, then plummeted by 74.92% to $174.2 million in 2022, then soared by 147.66% to $431.4 million in 2023, then crashed by 40.25% to $257.7 million in 2024, then crashed by 86.0% to $36.1 million in 2025.
  • Per Business Quant, the three most recent readings for RBB's Cash & Equivalents are $36.1 million (Q4 2025), $36.0 million (Q3 2025), and $191.9 million (Q2 2025).